Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disease of Liver and Bile Duct”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT04087876
What this trial is testing

Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations

Who this might be right for
Intrahepatic Cholangiocarcinoma
Basilea Pharmaceutica
Large-scale testing (Phase 3)Ended earlyNCT00658593
What this trial is testing

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
NCIC Clinical Trials Group 19
Testing effectiveness (Phase 2)Ended earlyNCT04251715
What this trial is testing

MFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

Who this might be right for
Liver and Intrahepatic Bile Duct CarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8+3 more
OHSU Knight Cancer Institute 5
Not applicableLooking for participantsNCT07149675
What this trial is testing

PBC Long-term Outcomes Study

Who this might be right for
Primary Biliary Cholangitis (PBC)Long-term OutcomesPrognosis+1 more
Beijing Friendship Hospital 4,000
Early research (Phase 1)Study completedNCT00943176
What this trial is testing

Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)

Who this might be right for
FatiguePrimary Biliary Cirrhosis
Mayo Clinic 40
Testing effectiveness (Phase 2)Study completedNCT05525520
What this trial is testing

Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Who this might be right for
Pruritus
Escient Pharmaceuticals, Inc 62
Not applicableStudy completedNCT04476082
What this trial is testing

Nutrition in Gastrointestinal Tumors

Who this might be right for
Pancreatic CancerOesophageal CancerColon Cancer+7 more
University Medicine Greifswald 66
Not applicableUnknownNCT06364969
What this trial is testing

Investigation of the Pruritogens of Liver-related Diseases

Who this might be right for
CholestasisIntrahepatic Cholestasis of Pregnancy
Peking University 200
Early research (Phase 1)Study completedNCT00004842
What this trial is testing

Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

Who this might be right for
Cholangitis, SclerosingLiver Cirrhosis, Biliary
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 22
Not applicableStudy completedNCT02846896
What this trial is testing

The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland

Who this might be right for
Primary Biliary Cirrhosis
Fondazione Epatocentro Ticino 501
Not applicableUnknownNCT03990623
What this trial is testing

CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization

Who this might be right for
Liver and Intrahepatic Bile Duct Carcinoma
M.D. Anderson Cancer Center 22
Not applicableAvailableNCT05448170
What this trial is testing

Linerixibat Compassionate Use for Cholestatic Pruritus Adult Patients With Primary Biliary Cholangitis (PBC)

Who this might be right for
Pruritus
GlaxoSmithKline
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Not applicableStudy completedNCT05011370
What this trial is testing

Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition

Who this might be right for
Intestinal Failure-associated Liver Disease
Protara Therapeutics 80
Large-scale testing (Phase 3)Study completedNCT00844402
What this trial is testing

Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary CirrhosisHypercholesterolemia
Medical University of Graz 40
Not applicableUnknownNCT02936596
What this trial is testing

Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

Who this might be right for
Hepatitis, AutoimmuneCholangitisLiver Cirrhosis, Biliary+1 more
Xiaoli Fan 53
Early research (Phase 1)Study completedNCT02963077
What this trial is testing

A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384

Who this might be right for
Orphan Cholestatic Liver DiseasesPrimary Biliary CirrhosisProgressive Familial Intrahepatic Cholestasis+1 more
Albireo 94
Not applicableLooking for participantsNCT06506734
What this trial is testing

Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia

Who this might be right for
Dental Diseases
University Hospital, Toulouse 120
Testing effectiveness (Phase 2)Ended earlyNCT03092765
What this trial is testing

Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid

Who this might be right for
Primary Biliary Cholangitis
EA Pharma Co., Ltd. 29
Testing effectiveness (Phase 2)Study completedNCT02117713
What this trial is testing

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc. 34
Next Page